Subsequent reports have also pointed out that the LCN2/24p3R/JNK/c‐Jun/SPARC axis is crucial in the malignant progression of GC, providing new prognostic markers and therapeutic targets [131]. This evidence concerns the gene LCN2 and gastric cancer.